Stay updated on Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page.

Latest updates to the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page’s Locations section has been expanded to include a large list of study sites across the United States, Canada, and several European countries. The HHS Vulnerability Disclosure notice has been removed.SummaryDifference2%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedPubMed publication attribution text was updated to state that publications are auto-filled from PubMed, and a new Revision: v3.3.2 was added. The older PubMed attribution sentence and Revision: v3.2.0 were removed.SummaryDifference0.1%

- Check46 days agoChange DetectedRemoved the notice about a lapse in government funding and the NIH Clinical Center's operating status, which previously informed users that updates may be delayed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check60 days agoChange DetectedNo additions or deletions detected on the Study Details page (NCT02132949 BERENICE); the content and layout appear the same across screenshots.SummaryDifference0.2%

- Check89 days agoChange DetectedKey updates: add an important operating-status notice and a new version tag (v3.2.0); remove the old version tag (v3.1.0).SummaryDifference1%

- Check96 days agoChange DetectedThe page now shows Revision: v3.1.0, replacing Revision: v3.0.2, indicating a version upgrade with potential new features or fixes.SummaryDifference0.0%

Stay in the know with updates to Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page.